Free Trial

Tenon Medical Q4 2023 Earnings Report

Tenon Medical logo
$2.47 -0.33 (-11.79%)
As of 03/28/2025 04:00 PM Eastern

Tenon Medical EPS Results

Actual EPS
-$0.68
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Tenon Medical Revenue Results

Actual Revenue
$0.81 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Tenon Medical Announcement Details

Quarter
Q4 2023
Time
N/A

Conference Call Resources

Remove Ads

Tenon Medical Earnings Headlines

Top Oil Stocks To Consider - March 25th
Trump's 100-Day Plan Triggers Global Retaliation
In the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code... And since then, "in the know" patriots have quietly used this same "Trump loophole" to shield their life savings from the economic chaos. But with Trump now forcefully bringing back millions of manufacturing jobs from Mexico, China, and the entire BRICS anti-dollar coalition...
Tenon Medical prices $2.5M registered direct offering at $2.00
See More Tenon Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Tenon Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tenon Medical and other key companies, straight to your email.

About Tenon Medical

Tenon Medical (NASDAQ:TNON), a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.

View Tenon Medical Profile

More Earnings Resources from MarketBeat